Method for heterologously producing cephalosporin C by using aspergillus nidulans
By overexpressing the biosynthetic gene of Ceptosporin in Aspergillus nitritis, the heterologous expression of cephalosporin C was achieved, and the problem of low yield in the prior art was solved, with the yield reaching 0.17g/L and it was cephalosporin. The high-yield regulation mechanism of protein C provides an effective expression system.
Patent Information
- Application Number
- CN202411417926.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-11
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art is difficult to effectively increase the yield of cephalosporin C and reduce its production cost, and there is a lack of a method for achieving heterologous expression of cephalosporin C in Aspergillus nitritis.
Overexpressing the biosynthetic genes pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT of A. nitritis in Aspergillus nitritis, the plasmids were constructed and introduced into the strains to achieve the heterogeneity of cephalosporin C by gene recombination technology. Source expression.
The heterologous expression of cephalosporin C was successfully achieved in Aspergillus nitritis strain, with a yield of 0.17g/L, opening up the biosynthesis path of cephalosporin C, and providing a good expression system for exploring the high-yield regulatory mechanism.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of microbial synthesis, and in particular to the application of genes in the heterologous synthesis of cephalosporin C, plasmids and strains. Background Art
[0002] Cephalosporin C (CPC) is a secondary metabolite produced by the filamentous fungus Acremonium chrysogenum and belongs to the β-lactam antibiotics. CPC is not easily destroyed by penicillinase and has the advantages of strong stability, broad antibacterial spectrum and low toxicity. After hydrolysis of CPC to remove the aminoadipoyl group on the side chain, 7-aminocephalosporanic acid (7-ACA) is obtained. 7-ACA is an intermediate of cephalosporin antibiotics widely used in clinical practice. Therefore, it is necessary to further reveal the molecular regulatory network of CPC synthesis, and to increase the yield of CPC and reduce its production cost through modern synthetic biology and metabolic engineering methods.
[0003] Aspergillus nidulans (A. nidulans) has a strong ability to produce secondary metabolites. Currently, A. nidulans strains with minimized genomes, such as A. nidulans A1145, have become a good natural product discovery and production platform. For example, by heterologously expressing the fungal biosynthesis gene cluster (BGC) of oxepinamides F, a potential drug for treating Alzheimer's disease and atherosclerosis, and circumdatin A / B, a potential drug for treating diabetes and inflammation, in A. nidulans, it has become a highly potential cell factory chassis cell. A. nidulans A1145 is a filamentous fungus with a clean background, which is particularly suitable as a biosynthetic chassis for fungal natural products. Since both Aspergillus nidulans and Cephalosporium acremonium contain peroxisomes, and the transperoxisomal transport of isopenicillin N and penicillin N is involved in the CPC biosynthesis pathway of Cephalosporium acremonium, Aspergillus nidulans can be used as a biosynthetic chassis for cephalosporin C, which has great application value for heterologous production of cephalosporin C and studying its synthetic regulation mechanism. Summary of the invention
[0004] In view of this, the present invention provides the use of CPC biosynthetic genes in the heterologous synthesis of cephalosporin C, plasmids and strains. The biosynthetic genes pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT from Cephalosporium acremonium were co-expressed in Aspergillus nidulans to obtain strain AnCPC01, which successfully achieved heterologous expression of cephalosporin C, and the yield reached 0.17 g / L at the shake flask level.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0006] The present invention provides an Aspergillus nidulans engineered bacterium for heterologously producing cephalosporin C. The engineered bacterium overexpresses pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT genes in a chassis Aspergillus nidulans to obtain the Aspergillus nidulans engineered bacterium capable of synthesizing cephalosporin C.
[0007] Preferably, the promoter of each gene is selected from amyB, gpdA, tef1 or glaA.
[0008] Specifically, a plasmid comprising pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT.
[0009] Preferably, the Aspergillus nidulans is an A1145 chassis cell strain.
[0010] The present invention provides a method for preparing the engineered Aspergillus nidulans bacteria, which overexpresses pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT genes in chassis Aspergillus nidulans by a gene recombination method, and preferably the promoter of each gene is selected from amyB, gpdA, tef1 or glaA.
[0011] Specifically, each gene is constructed into an expression plasmid and then introduced into the chassis Aspergillus nidulans. Preferably, the plasmid framework is a pYTP vector, a pYTR vector and a pYTU vector; further, the pcbAB gene is constructed into an expression plasmid, the cefD1, cefD2, cefM and cefT genes are constructed into an expression plasmid, and the pcbC, cefEF, cefG and cefP genes are constructed into an expression plasmid. A total of three expression plasmids are co-transformed into the chassis Aspergillus nidulans to obtain the Aspergillus nidulans engineered bacteria;
[0012] Specifically, the introduction is carried out by a protoplast transformation method.
[0013] The present invention further provides the use of the engineered Aspergillus nidulans in the preparation of cephalosporin C.
[0014] The present invention also provides a method for preparing cephalosporin C, which comprises fermenting and culturing the engineered Aspergillus nidulans to produce cephalosporin C, and optionally further comprising the step of separating the produced cephalosporin C.
[0015] Specifically, the fermentation culture conditions are pH 6.0-7.0, 35-38° C., 200-300 rpm, for 2-5 days.
[0016] In a specific embodiment, the separation is performed by collecting the fermentation broth and purifying it, specifically extracting it with ethyl acetate for 1-4 times, combining the organic phases and rotary evaporating them to complete dryness.
[0017] The present invention takes the Aspergillus nidulans engineered strain for heterologous synthesis of cephalosporin C as the target, and co-expresses and over-expresses the biosynthetic genes pcbAB, pcbC, cefD1, cefD2, cefEF and cefG, and the transporter genes cefM, cefP and cefT in the cephalosporin C biosynthetic gene cluster in the genome of Cephalosporin acremonium at the same time in Aspergillus nidulans, successfully opening up the biosynthetic pathway of cephalosporin C in Aspergillus nidulans, realizing heterologous expression of cephalosporin C, and the yield reaches 0.17 g / L at the shake flask level. The present invention proves that cefR is a non-essential gene for synthesizing cephalosporin C, and it is the first time to co-express these genes from Cephalosporin acremonium in Aspergillus nidulans, and realizes the synthesis of cephalosporin C in Aspergillus nidulans for the first time. The strain constructed by the present invention provides a good expression system for heterologous synthesis of cephalosporin C and exploring the high-yield regulation mechanism of cephalosporin C in Cephalosporin acremonium.
[0018] Therefore, the present invention uses Aspergillus nidulans A1145 strain as a chassis cell, utilizes yeast large fragment recombination technology to assemble an Aspergillus nidulans promoter, CPC biosynthesis gene, and terminator into an Aspergillus nidulans expression vector, reconstructs the biosynthesis pathway of cephalosporin C in Aspergillus nidulans, realizes the reconstruction of the cephalosporin C biosynthesis pathway in Aspergillus nidulans, and realizes the heterologous production of CPC. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the embodiments or the description of the prior art are briefly introduced below.
[0020] Figure 1A is a schematic diagram of plasmid pCPC01;
[0021] Figure 1B is a schematic diagram of plasmid pCPC02;
[0022] Figure 1C is a schematic diagram of plasmid pCPC03;
[0023] Figure 2 This is the LC-MS mass spectrum of the fermentation extract of strain AnCPC01.
[0024] Figure 3 This is a HPLC comparison chart of the fermentation product of AnCPC01 and cephalosporin C standard, as well as the UV absorption spectrum of the fermentation product. DETAILED DESCRIPTION
[0025] The present invention discloses the application of genes, plasmids and strains in the heterologous synthesis of cephalosporin C. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The methods and applications of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.
[0026] The present invention aims at an engineered strain of Aspergillus nidulans that heterologously synthesizes cephalosporin C, co-expresses and over-expresses biosynthetic genes derived from Cephalosporium acremonium in Aspergillus nidulans, obtains strain AnCPC01, successfully realizes the reconstruction of the cephalosporin C biosynthetic pathway, realizes the heterologous expression of cephalosporin C, and the yield reaches 0.17 g / L at the shake flask level.
[0027] Table 1. Primers used in constructing heterologous expression plasmids of the present invention
[0028]
[0029]
[0030] Note: Underlined sequences represent sequences that are homologous to the vector upstream or downstream of the fragment.
[0031] pcbAB F1 / R1, pcbAB F2 / R2, pcbC F / R, cefD1 F / R, cefD2 F / R, cefEF F / R, cefGF / R, cefM F / R, cefP F / R and cefT F / R were used as primer combinations, respectively.
[0032] Table 2. Plasmids used in the present invention
[0033]
[0034]
[0035] Table 3. Strains involved in the present invention
[0036]
[0037] The invention provides the application of the gene in the heterologous synthesis of cephalosporin C, the plasmid and the strain, and the raw materials and reagents used can all be purchased from the market.
[0038] The present invention will be further described below in conjunction with embodiments:
[0039] Example 1: Construction of plasmids pCPC01, pCPC02 and pCPC03 required for producing cephalosporin C strains
[0040] 1. Extraction of Cephalosporium acremonium genomic DNA
[0041] The cephalosporium acremonium ATCC11550 strain was purchased from the Guangdong Provincial Microbial Culture Collection Center (deposit number: GDMCCNO.3.616), hereinafter referred to as strain ATCC11550. Take the PDA solid plate (potato flour 20g, glucose 10g, agar powder 20g, water 1000mL) cultured for 3 days of strain ATCC11550, place it at -80°C and freeze for 20min, take it out and scrape the surface mycelium, wash it twice with distilled water and freeze-dry it and store it at -20°C. Use a liquid nitrogen pre-cooled mortar to grind the freeze-dried mycelium into fine powder, resuspend it in 500μL lysis buffer [40μmol / L Tris-acetate, 20μmol / L sodium acetate, 1μmol / LEDTA, 1% (w / v) SDS, pH 7.8], and pipette until the viscosity of the suspension is significantly reduced and foam is formed. Add RNAaseA and incubate at 37°C for 5 minutes, then add 165μL of 5μmol / L NaCl solution and mix. Centrifuge at 12000rpm for 20 minutes, immediately transfer the supernatant to a new EP tube, and add 400μL of chloroform and 400μL of phenol. Gently invert until the solution becomes milky. After centrifugation for 20 minutes, remove the aqueous phase and extract with an equal volume of chloroform. Use 2 volumes of 95% ethanol to precipitate the DNA in the supernatant. The precipitated DNA is washed 3 times with 70% pre-cooled ethanol, dried and dissolved in 50μLTE buffer (10μmol / LTris-HCl, 0.1μmol / L EDTA, pH7.8), and stored at -20°C.
[0042] 2. Amplification of target fragment
[0043] Primers for amplifying pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT sequences were designed based on the CPC biosynthetic gene sequences of the strain for the subsequent construction of pCPC01, pCPC02 and pCPC03 plasmids. These 9 gene sequences can be retrieved from the National Center for Biotechnology Information (NCBI, https: / / www.ncbi.nlm.nih.gov / ). The NCBI accession numbers are: pcbAB (X74601.1), pcbC (M33522.1), cefD1 (AJ507632.2), cefD2 (AJ507632.2), cefEF (CM008058.1), cefG (S83551.1), cefM (AM231815.1), cefP (:AM231816.1), and cefT (AJ487683.1).
[0044] Design corresponding primers to amplify the fragments and use them to construct pCPC01, pCPC02 and pCPC03 plasmids. The primer sequences are shown in Table 1 (underline indicates the repeating sequence at the junction of the gene and the vector or adjacent fragments):
[0045] The genomic DNA of strain ATCC11550 was used as a template, and pCbAB-F1 / R1 and pcbAB-F2 / R2 were used as primers to amplify the upper and lower fragments of the pcbAB gene. The demarcation point between the upper and lower parts was the sequence of pcbAB-1F2, that is, the upstream of this sequence was the upper part of pCbAB (pCbAB-up), and the downstream part of this sequence was the lower part of pCbAB (pCbAB-dn).
[0046] Using the genomic DNA of strain ATCC11550 as a template, pcbC-F / R, cefD1-F / R, cefD2-F / R, cefEF-F / R, cefG-F / R, cefM-F / R, cefP-F / R and cefT-F / R were used as primers to amplify the sequences of pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT, respectively, which were used to construct pYTR cefD1 / D2 / M / T and pYTUpcb C-cefEF / G / P.
[0047] The PCR amplification system is as follows:
[0048] template 1.5μL Primer F 1.5μL Primer R 1.5μL Q5enzyme 1uL dNTP(10mM) 1uL 5×Buffer 10μL Sterile water 33.5μL Total volume 50μL
[0049] The PCR amplification conditions were as follows: pre-denaturation at 94°C for 5 min, denaturation at 94°C for 30 s, annealing at 58°C for 30 s, extension at 72°C at 2 kb / min, 33 cycles, extension at 72°C for 5 min, and storage at 4°C.
[0050] 3. Extraction of pYTP, pYTR and pYTU vector plasmids
[0051] Use the Trans EasyPure Plasmid MiniPrep Kit to extract pYTP, pYTR and pYTU vector plasmids. The specific steps are as follows:
[0052] a. Grow E. coli containing pYTP, pYTR and pYTU vectors overnight, take 2-4 mL of bacterial culture, centrifuge at 10,000 rpm for 1 min, and pour off the supernatant.
[0053] b. Add 250 μL of RB solution (containing RNase A) to the collected bacteria and vortex until the bacteria are completely resuspended.
[0054] c. Add another 250 μL of LB solution to the centrifuge tube and gently invert the centrifuge tube 5-6 times.
[0055] d. Add 350 μL of NB solution to the centrifuge tube, gently invert the centrifuge tube 4-6 times, and let it stand at room temperature for 2 minutes.
[0056] e. Centrifuge at maximum speed for 10 minutes, carefully aspirate the supernatant and add it to the centrifugal collection column, centrifuge at 10,000×g for 1 minute, and discard the waste liquid in the collection tube.
[0057] f. Add 650 μL of WB solution to the centrifuge column (80 mL of anhydrous ethanol must be added before use), centrifuge at 12,000 × g for 1 min, discard the waste liquid in the collection tube, and repeat once.
[0058] g. Place the centrifuge column in a clean 1.5 mL centrifuge tube, add 50 μL of sterile water (preheated to 60-70°C) to the centrifuge column, and let it stand at room temperature for 2 minutes.
[0059] h. Centrifuge at 12000×g for 1 min and store the plasmid DNA at -20℃.
[0060] 4. Enzyme digestion of the vector and recovery of the vector and target fragment
[0061] pYTP and pYTR vectors were digested with SwaI and BamHI endonucleases, and the digestion buffer was NEBuffer 3.1.
[0062] The pYTU vector was double-digested with SwaI and NotI, and the digestion buffer was NEBuffer 3.1.
[0063] The SwaI enzyme digestion temperature is 25°C, the BamHI and NotI enzyme digestion temperatures are 37°C, and the digestion time is 6 hours. The digestion system is as follows:
[0064] pYTP / pYTU / pYTR vector 5μg 10×NEBuffer 3.1 2uL Endonuclease 2uL Sterile water Make up to 20 μL Total volume 20uL
[0065] The vector and target fragment after enzyme digestion were recovered using the OMEGA Gel Extraction Kit. The specific steps are as follows:
[0066] a. Place the cut gel pieces into a 2 mL centrifuge tube, add an equal volume of Binding buffer, and incubate at 60°C until the gel is completely dissolved.
[0067] b. Transfer the solution to a DNA binding column, centrifuge at 12,000 × g for 1 min, and discard the waste liquid in the collection tube.
[0068] c. Add 700 μL SPW Wash Buffer (100 mL ethanol should be added to SPW Wash Buffer before use) to the DNA binding column, centrifuge at 12,000 × g for 1 min, discard the waste liquid in the collection tube, and repeat once.
[0069] d. Place the empty DNA binding column into a collection tube and centrifuge at 12,000 × g for 2 min.
[0070] f. Place the DNA binding column in a clean 1.5 mL centrifuge tube, add 30-40 μL of ultrapure water (preheated to 65°C), and let stand at room temperature for 2 minutes.
[0071] g. Centrifuge at 12000×g for 1 min and store the DNA at -20°C.
[0072] 5. Yeast assembly to obtain yeast transformants containing pCPC01, pCPC02 and pCPC03 plasmids
[0073] 5.1. Preparation of competent yeast
[0074] The competent state of yeast strain BJ5464-NpgA (purchased from BioVector NTCC) was prepared. The competent state preparation refers to the kit: Zymo research-Yeast Transformation II Kit, Catalog No.: T2001. The detailed steps are as follows:
[0075] (1) 15 μL of yeast cells were inoculated into 10 mL of YPD medium and cultured for 18-22 h at 30°C and 220 rpm until the yeast reached the logarithmic phase (OD 600 Between 0.8 and 1.0);
[0076] (2) Centrifuge at 500 g for 4 min at room temperature to collect yeast;
[0077] (3) Wash the yeast pellet with 5 mL of EZ1 solution at room temperature and collect the yeast by centrifugation at 500 g for 4 min.
[0078] (4) At room temperature, wash the yeast pellet again with 5 mL of EZ1 solution and collect the yeast by centrifugation at 500 g for 4 min.
[0079] (5) At room temperature, resuspend the yeast pellet with 1 mL of EZ2 solution, dispense 25 μL into each EP tube to obtain competent yeast, and freeze at -80°C for future use.
[0080] 5.2 Yeast homologous recombination transformants
[0081] (1) Yeast competent state after thawing at room temperature;
[0082] (2) Add 0.5 μg of the pYTP vector, pcbAB-up, and pcbAB-dn fragments after restriction digestion to 25 μL of yeast competent medium, add 0.5 μg of the pYTR vector and cefD1 / cefD2 / cefM / cefT fragments after restriction digestion to another 25 μL of yeast competent medium, and add 0.5 μg of the pYTU vector and pcbC / cefEF / cef G / cefP fragments after restriction digestion to another 25 μL of yeast competent medium.
[0083] (3) Incubate at 30°C for 1 h, vortexing and mixing every 15 min. The incubation time can be extended to 2 h.
[0084] (4) Spread the entire transformation system onto UDMS medium (0.5 g Bactotechnical grade casamino acids; 2 g glucose; 2 g agar powder; add 10 mL 10x nitrogen base stock, 1 mL tryptophan stock solution, 1 mL adenine stock solution, 100 mL deionized water) and culture at 30°C for 2-4 days.
[0085] 5.3 Identification of transformants
[0086] Pick 4-5 transformants and identify them by colony PCR. 2 Transfer to the plate, and after 1 day, perform PCR colony verification on the expanded yeast monoclonal transformants.
[0087] Yeast colony PCR bacterial pretreatment steps:
[0088] Scrape the yeast monoclone from the plate into a 1.5mL EP tube, suspend the cells in 100μL of 0.2mM lithium acetate solution containing 1% SDS, and incubate at 70°C for 5min; then add 300μL of 96-100% ethanol to the 1.5mL EP tube and vortex to mix; put the 1.5mL EP tube into a centrifuge and centrifuge at 15000g for 3min; pour out the supernatant, add 200μL of 70% ethanol to the 1.5mL EP tube to wash the residue, centrifuge at 15000g for 2-3min, discard the supernatant and place the precipitate in a 60°C oven for 5min to evaporate the ethanol; finally, resuspend the residue with 15μL of ultrapure water, shake well on a vortex mixer, and centrifuge at 15000g for 15s.
[0089] Take 1 μL of supernatant as PCR template for plasmid assembly verification. pCPC01 plasmid was sequenced using pYTP-SF / SR primers; pCPC022 plasmid was sequenced using pYTR-SF / SR primers; pCPC03 plasmid was sequenced using pYTU-SF / SR primers. The primer sequences are as follows:
[0090] Table 4. Sequencing primer sequences
[0091] Sequence (5'-3') pYTP-SF CTTGGAGGATAGCAACCGACAACA pYTP-SR TCCAGCATCTGATGTCCCTATCAG pYTR-SF CTCCTCTCGTCTCCTCACGAAG pYTR-SR TGATCAAACGAGCCAGACTCCT pYTU-SF GGCTGAAGTGCTTCCTCCCTTTTA pYTU-SR TTAATGAGCTTCAAATTATCGATTGT
[0092] The sequence obtained by sequencing is compared with the target sequence, and the consistency of the sequences indicates that the constructed plasmid is correct.
[0093] 5.4. Yeast plasmid extraction
[0094] Scrape 1x1 cm pieces of yeast cells containing the correctly identified pCPC01, pCPC02 and pCPC03 plasmids from the plate. 2 The extraction process refers to the kit: Zymoresearch Zymoprep II Yeast Plasmid Miniprep II Kit, Catalog No.: D2004.
[0095] 5.5 Introducing yeast plasmids into E. coli Top10 for plasmid amplification
[0096] Commercial E. coli Top10 was used for plasmid amplification, and the transformation method was as follows:
[0097] Take out Top10 competent cells from -80℃ freezer and put them on ice to thaw; add 10μL assembly solution, mix gently, and place on ice for 30min; put them in a 42℃ water bath for 60-90s, take them out and put them on ice for 2min; add 200μL LB medium (10g / L peptone, 5g / L yeast powder, 10g / LNaCl), and incubate them in a shaker at 37℃ for 1h; spread the culture medium on LB solid plate containing 100μg / mL ampicillin resistance and culture overnight; pick out the grown single clones and culture them with LB liquid medium containing 100μg / mL ampicillin resistance for 12h, and extract plasmids pCPC01, pCPC02 and pCPC03.
[0098] 5.6 Verification of plasmids pCPC01, pCPC02, and pCPC03
[0099] The extracted plasmid was sent to a sequencing company for sequencing. pCPC01 plasmid was sequenced using pYTP-SF / SR primers; pCPC02 plasmid was sequenced using pYTR-SF / SR primers; pCPC03 plasmid was sequenced using pYTU-SF / SR primers. The primer sequences are the same as in Table 4. The sequence obtained by sequencing was compared with the target sequence. If the sequence was consistent, it means that the constructed plasmid was correct.
[0100] Example 2: Transformation of pCPC01, pCPC02 and pCPC03 plasmids into Aspergillus nidulans A1145 strain
[0101] 1. The preparation method of Aspergillus nidulans protoplasts is as follows:
[0102] A. nidulans A1145 strain (purchased from BioVector NTCC) was spread or streaked on a solid CD medium containing 0.5 μg / mL vitamin B (pyridoxine HCl), 0.125 μg / mL riboflavin and 10 mM uridine, and cultured at 37°C for about 4 days. After the plate was fully grown, 2 mL of 0.1% Tween-80 was added, and spores on about half of the plate were scraped with a cotton swab and filtered using a spore filter. The solid CD medium formula is: 20g / L tryptone; 50mL / L 20x nitrate solution (120g NaNO3; 10.4g KCl; 10.4g MgSO4·7H2O; 30.4g KH2PO4 dissolved in 1L water); 1mL / L trace elements [2.20g ZnSO4·7H2O; 1.10g H3BO3; 0.50g MnCl2·4H2O; 0.16g FeSO4·7H2O; 0.16g CoCl2·6H2O; 0.16g CuSO4·5H2O; 0.11g (NH4)6Mo7O 24·4H2O; 5.00g Na4EDTA]; 20g agar; dissolved in 1L water.
[0103] The spores were inoculated into 100 mL of liquid CD medium containing 0.5 μg / mL vitamin B (pyridoxine HCl), 0.125 μg / mL riboflavin, and 10 mM uridine. The spore concentration under microscopic examination was about 10 7 / mL. The formula of liquid CD medium is 20g / L tryptone; 50mL / L 20xNitrate salts medium; 1mL / L trace elements. The pH value is adjusted to 6.5 with 1M KOH, and the shaking culture conditions are 37℃, 250rpm. The spores germinate for 6.5h. The best state of spore germination is that the mycelium grows to 3 times the size of the expanded spores, and the spores gather first and then germinate.
[0104] The mycelium in the culture medium was centrifuged at 8000 rpm for 5 min, 15 mL of osmotic buffer Osmotic Medium (1.2 M MgSO4, 10 mM sodium phosphate buffer, pH 5.8) was added, and the washing was repeated 3 times.
[0105] Add 10mL of mixed enzymatic solution (30mg Lysing Enzyme, 20mg Yatalase dissolved in 10mL Osmotic Medium buffer), culture in a shaker at 30°C, 80rpm, and observe the enzymatic hydrolysis of mycelium under a microscope. The protoplasts after enzymatic hydrolysis are about twice the volume of spores, with uniform morphology and thin walls. The enzymatic hydrolysis time is generally about 2.5h.
[0106] Three volumes of STC buffer (1.2 M sorbitol; 10 mM CaCl2; 10 mM Tris-HCl, pH 7.5) were added, and the mixture was centrifuged at 5000 rpm for 10 min, and the liquid was removed.
[0107] Add a small amount of STC buffer to resuspend the protoplasts to a concentration of about 10 8 -10 9 pcs / mL, and dispense into 1.5mL centrifuge tubes, 100μL per tube. All the above operations were performed on ice or at 4℃.
[0108] 2. Transform the pCPC01, pCPC02 and pCPC03 plasmids into Aspergillus nidulans protoplasts
[0109] Here are the steps:
[0110] Take 5 μg of each of pCPC01, pCPC02 and pCPC03 plasmids, add them together to 100 μL of protoplasts, mix gently, and place on ice for 60 minutes.
[0111] Add 1.25 mL of 60% PEG solution (60% PEG4000; 50 mM CaCl2; 50 mM Tris-HCl, pH 7.5), mix gently with a pipette, and leave at room temperature for 20 min.
[0112] Gently spread on a solid CD-Sorbitol medium (10g / L glucose; 50mL / L 20x nitrate; 1mL / L trace elements; 1.2M sorbitol; 20g / L agar) plate, and be gentle when mixing and spreading. Incubate upright at 37℃ for 1 day, then invert for 1-2 days, and wait for clones to grow to obtain the engineered strain of Aspergillus nidulans.
[0113] 3. Identification of Aspergillus nidulans products
[0114] Take a single clone transformant and transfer it to solid CDMedium, and culture the transformant strain at 37℃ for seed preservation;
[0115] The bacterial cells obtained in the above step were inoculated into liquid CD-ST Medium and cultured at 37° C. and 250 rpm for 3 days. The fermentation broth was extracted and the fermentation product was detected. The strain capable of producing CPC was the engineered strain of Aspergillus nidulans AnCPC01.
[0116] Example 3: Detection of CPC by the engineered strain AnCPC01 of Aspergillus nidulans
[0117] Detection of CPC production of engineered strain AnCPC01
[0118] The verified correct strain AnCPC01 was inoculated (10 8 The spore suspension of 100 μL / mL was inoculated into 50 mL of liquid CD-ST medium (20 g / L starch; 20 g / L tryptone; 50 mL / L 20x nitrate; 1 mL / L trace elements; pH adjusted to 6.5) for shake flask fermentation, and samples were taken after culturing for 3 days at 37°C and 250 rpm in a shaker.
[0119] Take 50 mL of fermentation broth, extract the mycelium and supernatant with ethyl acetate three times, combine the organic phases, evaporate at 30°C until completely dry, add 300 μL of methanol to dissolve, filter with 0.22 μm filter membrane, and use high performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) to detect CPC.
[0120] LC-MS detection conditions of CPC: LC-MS analysis was performed on an Agilent-1200HPLC / 6520QTOFMS (USA) system, with acetonitrile (v / v, 0.1% formic acid) and water (v / v, 0.1% formic acid) as the mobile phase, a flow rate of 0.8 mL / min, and an injection volume of 5 μL. 0-15 min, 5%-95% acetonitrile; 15-20 min, 95% acetonitrile. The Q-TOF used dual ESI as the ion source interface, and the ESI source was operated in positive ionization mode. The scan range was m / z 100-1000. The obtained sample mass spectrum ( Figure 2 ), which is consistent with CPC standard.
[0121] HPLC analysis conditions were as follows: 10% methanol was used to balance the column before injection, the mobile phase was 98.7% (v / v) 0.01 M sodium acetate (adjusted to pH 4.75 with acetic acid), 1.3% (v / v) acetonitrile, flow rate was 1.0 mL / min, injection volume was 5 μL, and isocratic analysis was performed from 0 to 22 min. The absorption peak of CPC in the fermentation product was consistent with the retention time of CPC standard ( Figure 3 ), the characteristic peak of ultraviolet absorption is 259.5nm.
[0122] The quantification of CPC was calculated by the standard curve measured by HPLC analysis:
[0123] The CPC standard of 200.0 mg / mL was diluted by half-half dilution method and filtered with 0.22 μm filter membrane. 5 μL of each sample was injected for HPLC analysis and detected at 254 nm. The injection needle was cleaned with methanol for each analysis. The sample concentration was set to x (= 0, 20, 40, 80, 100, 150, 200 mg / mL), and the peak area of CPC at 254 nm displayed by HPLC was set to y, and the regression equation of CPC was obtained, y = 5427200x-123748 (R 2 =0.9985), and the linear range was 0-200.0 mg / mL.
[0124] If the sample concentration exceeds the linear range, dilute the sample before testing.
[0125] The fermentation extracts were analyzed by HPLC, and the CPC yield data in the fermentation extracts were calculated. Three replicates were set for each sample.
[0126] like Figure 2 As shown in Figure 2, the LC-MS detection results of the fermentation product showed that the Aspergillus nidulans strain AnCPC01 produced CP C. The corresponding HPLC spectrum is shown in Figure 2. Figure 3 As shown, the yield of CPC produced heterologously by AnCPC01 strain reached 170.2 mg / L.
[0127] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. An engineered Aspergillus nidulans strain for heterologous production of cephalosporin C, characterized in that: The pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT genes were overexpressed in the chassis Aspergillus nidulans to obtain an engineered Aspergillus nidulans strain with the ability to synthesize cephalosporin C.
2. The engineered Aspergillus nidulans according to claim 1, characterized in that The promoter of each gene is selected from amyB, gpdA, tef1 or glaA.
3. The engineered Aspergillus nidulans according to claim 1, characterized in that A plasmid comprising pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT.
4. The engineered Aspergillus nidulans according to claim 1, characterized in that The chassis Aspergillus nidulans is the A1145 chassis cell strain.
5. A method for preparing the engineered Aspergillus nidulans according to any one of claims 1 to 4, characterized in that: The pcbAB, pcbC, cefD1, cefD2, cefEF, cefG, cefM, cefP and cefT genes are overexpressed in Aspergillus nidulans by gene recombination, and preferably the promoter of each gene is selected from amyB, gpdA, tef1 or glaA.
6. The method according to claim 5, characterized in that Each gene is constructed into an expression plasmid and then introduced into the chassis Aspergillus nidulans. Preferably, the plasmid framework is a pYTP vector, a pYTR vector and a pYTU vector; further, the pcbAB gene is constructed into an expression plasmid, the cefD1, cefD2, cefM and cefT genes are constructed into an expression plasmid, and the pcbC, cefEF, cefG and cefP genes are constructed into an expression plasmid. A total of three expression plasmids are co-transformed into the chassis Aspergillus nidulans to obtain the Aspergillus nidulans engineered bacteria; Specifically, the introduction is carried out by a protoplast transformation method.
7. Use of the engineered Aspergillus nidulans according to any one of claims 1 to 4 in the preparation of cephalosporin C.
8. A method for preparing cephalosporin C, characterized in that: Fermentation and culturing the engineered Aspergillus nidulans according to any one of claims 1 to 4 to produce cephalosporin C, optionally, further comprising the step of isolating the produced cephalosporin C.
9. The method according to claim 8, characterized in that The fermentation culture conditions are pH 6.0-7.0, 35-38°C, 200-300 rpm for 2-5 days.
10. The method according to claim 8, characterized in that The separation is carried out by collecting the fermentation broth and purifying it, specifically extracting it with ethyl acetate for 1-4 times, combining the organic phases and then rotary evaporating them to complete dryness.
